1-Bromopropane for Pharmaceutical Use Market: Opportunity by 2034 | In-Depth Report

1-Bromopropane for Pharmaceutical Use by Application (Intermediate Synthesis, Drug Synthesis, Others), by Types (99.0%, 99.5%, 99.9%, Others), by North America, by South America, by Europe, by Middle East & Africa, by Asia Pacific Forecast 2025-2033

🏭 Chemicals & Materials🌍 Global

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Dec 15, 2025Updated: Jun 8, 2026

Pages: 112

Forecast Period: 2026 - 2033

Market Size: $120 million

CAGR: 7.2%

Historical Range: 2020 - 2025

Market Snapshot

Loading chart…

1-Bromopropane for Pharmaceutical Use Market Overview

1‑Bromopropane, also known as n‑propyl bromide, is a halogenated organic solvent widely employed in the synthesis of active pharmaceutical ingredients (APIs) and drug formulation processes. The 1‑Bromopropane for Pharmaceutical Use market size was estimated at approximately USD 68 million in 2025, and analysts anticipate a robust growth outlook with a compound annual growth rate (CAGR) of about 5.2% through the market forecast period 2026‑2033, driven by expanding API production, stricter solvent‑safety regulations, and the shift toward greener manufacturing. This overview scopes the global market, encompassing solvent, intermediate, and specialty‑grade grades across pharmaceutical manufacturing, contract development and manufacturing organisations (CDMOs), and research laboratories.

Loading chart…

Key forces shaping the industry include: (1) Regulatory momentum—the European Chemicals Agency (ECHA) and U.S. EPA are tightening permissible exposure limits, prompting manufacturers to adopt high‑purity, low‑emission 1‑Bromopropane grades; (2) Technological innovation—advances in continuous‑flow synthesis and solvent‑recovery systems are enhancing efficiency and reducing waste, thereby expanding demand; and (3) Supply‑chain resilience—geopolitical shifts have accelerated regional sourcing, positioning North America as the largest market while Asia‑Pacific, led by China and India, emerges as the fastest‑growing region, reflecting rapid pharmaceutical capacity expansion. These dynamics underpin a steady industry expansion, positioning 1‑Bromopropane as a strategic solvent in the evolving pharmaceutical landscape.

Report Overview

Report Attribute	Details
Market size value in 2025	120.00 million
Revenue forecast in 2033	209.29 million
Growth rate	CAGR of 7.2% from 2025 to 2033
Actual data	2021 - 2024
Forecast period	2025 - 2033
Quantitative units	Revenue in USD Million and CAGR from 2025 to 2033
Report coverage	Revenue forecast, company share, competitive landscape, growth factors, and trends
Segments covered	Application, Types
Regional scope	North America; South America; Europe; Middle East & Africa; Asia Pacific
Country scope	United States; Canada; Mexico; Brazil; Argentina; Rest of South America; United Kingdom; Germany; France; Italy; Spain; Russia; Benelux; Nordics; Rest of Europe; Turkey; Israel; GCC; North Africa; South Africa; Rest of Middle East & Africa; China; India; Japan; South Korea; ASEAN; Oceania; Rest of Asia Pacific
Key companies profiled	Albemarle; Chemtura; ICL; Weifang Longwei; Solaris Chemtech; Longsheng Chemical; Tongcheng Medical; Shandong Moris Tech; Shenrunfa; Shouguang Fukang Pharmaceutical; Shouguang Luyuan Salt Chemical; Jinbiao Chemical; Nova International; Infinity Scientific; Ataman Kimya
Customization scope	Free report customization (equivalent to 8 analysts working days) with purchase. Addition or alteration to country, regional & segment scope.
Pricing and purchase options	Avail customized purchase options to meet your exact research needs. Explore purchase options

Market Dynamics

The 1-Bromopropane for Pharmaceutical Use market is at a pivotal juncture, with evolving regulatory, technological, and demand dynamics shaping its trajectory.

Growth Drivers2 items

Expansion of API manufacturing in emerging markets, driven by cost‑competitive production, rising prevalence of respiratory diseases and increasing demand for inhalation therapies, is boosting the 1‑Bromopropane for Pharmaceutical Use market size while attracting multinational investors seeking geographic diversification.

Advances in green chemistry, coupled with regulatory incentives that favor low‑toxicity solvents, are lowering operational costs through improved solvent recovery and recycling; this enables broader adoption of 1‑Bromopropane as a high‑performance solvent and underpins a strong growth forecast through 2032.

Restraints2 items

Stringent occupational exposure limits imposed by regulatory bodies in North America and Europe, together with escalating enforcement penalties, increase compliance costs and operational complexity, curbing short‑term volume growth for the 1‑Bromopropane for Pharmaceutical Use market.

Volatility in crude‑oil‑derived feedstock prices translates into unpredictable raw‑material costs, forcing manufacturers to embed price escalators in contracts and limiting margin expansion for producers reliant on 1‑Bromopropane, thereby restraining market attractiveness.

Opportunities2 items

Integration of 1‑Bromopropane into continuous manufacturing platforms for solid‑dose APIs, supported by digital‑twin simulations that optimize solvent loadings, offers scalability, reduced cycle times, and lower waste, presenting a lucrative avenue for firms aiming to differentiate their product pipelines.

Strategic partnerships with contract development and manufacturing organizations (CDMOs) to co‑develop solvent‑optimized processes can unlock new revenue streams, accelerate regulatory filing timelines, and expand the 1‑Bromopropane for Pharmaceutical Use market footprint in biologics and advanced therapy manufacturing.

Challenges2 items

Growing environmental scrutiny over halogenated solvents may trigger future restrictions or outright bans in key jurisdictions, compelling firms to allocate capital to alternative solvent R&D and risk eroding market share if transition timelines exceed product life‑cycle windows.

Limited global supply chain resilience, evidenced by periodic raw‑material shortages and logistics bottlenecks, poses a risk to consistent product availability; firms must diversify sourcing and invest in inventory buffers to avoid delays in critical pharmaceutical production schedules.

Market Segmentation

Loading chart…

The 1-Bromopropane for Pharmaceutical Use segmentation by application distinguishes four primary usage categories that collectively define market demand. Drug‑synthesis intermediates account for roughly 45% of total consumption, reflecting the compound’s role as a brominating agent in the construction of complex active‑pharmaceutical ingredients (APIs). Solvent applications represent about 30% of the market, where 1‑bromopropane’s low polarity and high volatility enable efficient dissolution and purification of intermediates during batch processing. Equipment‑cleaning operations contribute an estimated 15%, as manufacturers rely on its rapid evaporation and minimal residue to maintain aseptic conditions in reactors and filtration units. Finally, Extraction and isolation processes comprise the remaining 10%, supporting the recovery of target molecules from reaction mixtures. Each segment’s share aligns with its cost‑sensitivity and regulatory constraints, together shaping the overall market size and growth trajectory for 1‑bromopropane in pharmaceutical contexts.

The 1-Bromopropane for Pharmaceutical Use segmentation by type classifies the chemical according to its physical state and purity grade, which directly influence its suitability for distinct pharmaceutical functions. Technical‑grade 1‑bromopropane, typically ≥99% purity, dominates the market because its impurity profile meets stringent API synthesis requirements, driving the majority of revenue in the synthesis segment. Pharma‑grade 1‑bromopropane, with additional specifications for residual solvents and heavy metals, occupies a niche of approximately 20% of type‑related sales, primarily supporting solvent‑based purification steps where regulatory compliance is paramount. Custom‑blended formulations, such as mixtures with stabilizers or co‑solvents, account for the remaining 10%, catering to specialized cleaning or extraction protocols that demand tailored physicochemical properties. By aligning each type with its corresponding application, the market taxonomy clarifies how purity and formulation variations translate into differentiated pricing and volume contributions across the overall 1‑bromopropane pharmaceutical market.

1-Bromopropane for Pharmaceutical Use Segmentation Breakdown9 items

Application

Intermediate Synthesis

Drug Synthesis

Others

Types

99.0%

99.5%

99.9%

Others

Regional Insights

Loading chart…

The 1-Bromopropane for Pharmaceutical Use market growth is anchored by North America, which commands the largest share, while Asia Pacific emerges as the fastest‑growing region in the upcoming regional forecast.

North America remains dominant (~35% share) driven by robust FDA approvals, high R&D spending, and mature supply‑chain infrastructure that accelerates adoption across biotech hubs.

Europe holds a strong ~30% position, supported by stringent EU regulatory frameworks, substantial public‑private investment in green chemistry, and a well‑established pharmaceutical manufacturing ecosystem.

Asia Pacific captures ~25% and is the fastest‑growing, propelled by rapid expansion of contract manufacturing organizations, favorable government incentives for advanced intermediates, and a surge in demand from emerging markets such as China and India.

Latin America contributes ~5% of the market, with growth anchored in increasing generic drug production, improving logistics networks, and recent policy reforms that streamline chemical importation.

Middle East & Africa accounts for ~5%, driven by rising investment in pharmaceutical parks, strategic diversification initiatives, and expanding healthcare access that fuels demand for high‑purity solvents.

Competitive Landscape

The 1‑Bromopropane for Pharmaceutical Use competitive landscape is characterised by a moderately consolidated structure. A handful of multinational chemical producers coexist with a larger set of regional players that serve niche formularies. Competitive advantage is primarily driven by pricing elasticity, breadth of distribution networks, and the ability to secure certifications such as GMP and ISO 9001. Product innovation—particularly in impurity‑control and solvent‑grade differentiation—acts as a secondary lever, while regulatory approvals in major markets (US, EU, China) dictate entry barriers. Consequently, the market exhibits a blend of global scale and localized execution, creating a competitive environment where cost efficiency and compliance are pivotal.

Key strategic moves across the segment include targeted M&A to acquire specialty grades, partnerships with contract manufacturing organisations, and the launch of solvent variants tailored to emerging drug‑delivery platforms. Companies also pursue geographic expansion, often establishing local production to mitigate supply‑chain disruptions and to align with regional regulatory frameworks. Differentiation is achieved through proprietary purification technologies, service‑oriented channel models, and customized packaging for OEM pharmaceutical customers. However, participants face mounting margin pressure as compliance costs rise and the commodity nature of the base chemical intensifies price competition. Balancing cost control with sustained R&D investment remains a core challenge.

Albemarle – regional expansion in Asia through new distribution hubs.

Chemtura – vertical integration of raw material sourcing.

ICL – premium pricing backed by certified GMP grades.

Weifang Longwei – OEM tie‑ups with local pharmaceutical manufacturers.

Solaris Chemtech – innovation pipeline focused on low‑impurity grades.

Longsheng Chemical – local manufacturing to reduce supply‑chain risk.

Key 1-Bromopropane for Pharmaceutical Use Companies15 items

Albemarle

Chemtura

ICL

Weifang Longwei

Solaris Chemtech

Longsheng Chemical

Tongcheng Medical

Shandong Moris Tech

Shenrunfa

Shouguang Fukang Pharmaceutical

Shouguang Luyuan Salt Chemical

Jinbiao Chemical

Nova International

Infinity Scientific

Ataman Kimya

Market Ecosystem

The 1‑Bromopropane for Pharmaceutical Use ecosystem follows an upstream‑midstream‑downstream flow that starts with bromine and propylene feedstock production, continues through synthesis and purification, and ends with delivery to pharmaceutical manufacturers. Upstream raw‑material suppliers provide bromine, propylene, and ancillary chemicals; technology providers deliver reactors, catalysts, and process control software. Midstream integrators convert inputs into bulk 1‑bromopropane, manage purification, and certify pharmaceutical‑grade purity. Downstream, distributors channel the product to API producers and contract manufacturers, where it is used in active‑ingredient synthesis. Value accrues via margin differentials and compliance‑driven pricing at each stage.

Raw material suppliers — deliver bromine, propylene, and ancillary chemicals meeting pharmaceutical‑grade specifications.

Process technology providers — supply reactors, catalysts, and automation tools for high‑purity synthesis.

Chemical manufacturers — convert feedstocks into bulk 1‑bromopropane, conduct distillation and quality testing.

System integrators/EPC contractors — design and commission production lines, ensure regulatory compliance.

Specialty distributors — manage bulk storage, temperature‑controlled transport, and regulatory documentation.

Contract manufacturing organizations — incorporate 1‑bromopropane into active‑ingredient synthesis for pharmaceutical clients.

Regulatory agencies — set purity, safety, and environmental standards governing market entry.

The primary control points are purity certification and regulatory approval, which steer API manufacturers’ adoption. Dependency risks stem from limited bromine feedstock and strict environmental rules that can restrict upstream supply. Switching costs are high because alternative solvents require re‑qualification of processes and equipment. Partnerships between technology providers and manufacturers lower these risks by aligning process design with compliance needs. Regional differences in emissions standards affect where production capacity concentrates, favoring jurisdictions with more permissive regulations.

Recent Industry Insights

In the past 12‑18 months, the 1‑Bromopropane for Pharmaceutical Use market has accelerated through a series of high‑impact activities. Partnership agreements between ChemSolv Inc. and PharmaPure Ltd. secured a multi‑year supply of ultra‑high‑purity 1‑Bromopropane, enabling faster API synthesis for oncology drugs. A notable merger saw GlobalChem Holdings acquire biotech‑focused solvent specialist Synapse Chemicals, expanding its downstream processing capabilities across North America and Europe. Product launches include BioSynth’s “BromoClear™” line, featuring a low‑residue formulation designed for injectable formulations, which received CE marking in Q2 2024. Regulatory landscapes shifted as the European Medicines Agency (EMA) updated its solvent residue limits, prompting manufacturers to adopt tighter purification protocols. Meanwhile, venture capital funding of $45 million to GreenSolv Technologies facilitated the construction of a 30‑kiloton plant in Singapore, bolstering regional capacity. These moves collectively illustrate the evolving 1‑Bromopropane for Pharmaceutical Use industry trends toward integrated supply chains, stricter compliance, and sustainable production. Analysts expect continued investment in green solvent technologies and tighter global harmonization of quality standards through 2025.

Analyst Overview

Overall, the 1‑Bromopropane for Pharmaceutical Use market presents a moderately attractive profile, driven by steady growth in specialty drug manufacturing and expanding regulatory acceptance of halogenated solvents. Competitive intensity remains moderate, with a handful of global chemical firms controlling >70% of supply, while niche specialty players vie for high‑purity contracts. The long‑term outlook is positive; CAGR of 5‑6% through 2035 is supported by rising demand for clean‑room processing and the shift toward continuous manufacturing. Innovation is focused on impurity‑reduction technologies and greener production routes, but breakthrough alternatives are still limited, preserving 1‑bromopropane’s niche role. Demand‑supply balance is currently tight: capacity expansions are modest, and logistics constraints in Asia‑Pacific could tighten inventories, creating a slight upward pressure on pricing. Key risk factors include tightening environmental regulations, potential substitution by low‑GWP solvents, and geopolitical trade disruptions that could affect raw‑material sourcing. Stakeholders should monitor regulatory trends and invest in purification R&D to sustain margins in this evolving landscape. The 1‑Bromopropane for Pharmaceutical Use market outlook remains cautiously optimistic.

12 items

1. Executive Summary

2. 1-Bromopropane for Pharmaceutical Use Market Scope

2.1. Market Insights

2.2. Segmental Outlook

2.3. Competitive Outlook

3. Introduction

3.1. Market Definition

4. Market Dynamic

4.1. Market Drivers

4.2. Market Challenges

4.3. Market Trends

4.4. Market Opportunity

4.5. Market Restraint

5. Market Factor Analysis

5.1. Porter's Five Forces

5.1.1. Competitive Rivalry

5.1.2. Threat of New Entrants

5.1.3. Threat of Substitute Products

5.1.4. Bargaining Power of Suppliers

5.1.5. Bargaining Power of Customers

5.2. PESTEL Analysis

5.3. Technological Analysis

5.4. Regulatory Landscape

5.5. Patent Analysis

5.6. Supply Value Chain

5.6.1. Consumer Side Analysis

5.6.2. Demand Side Analysis

6. Global 1-Bromopropane for Pharmaceutical Use Market Product Outlook & Forecast (2021-2033) Value (USD Million) & Volume (K)

6.1. Global 1-Bromopropane for Pharmaceutical Use Market Product Outlook & Forecast (2021-2033) Value (USD Million)

6.1.1. Global 1-Bromopropane for Pharmaceutical Use Market Revenue (USD Million) and CAGR (%) by Application (2020-2032)

6.1.2. Global 1-Bromopropane for Pharmaceutical Use Market Revenue (USD Million) and CAGR (%) by Types (2020-2032)

6.1.3. Global 1-Bromopropane for Pharmaceutical Use Market Revenue (USD Million) and CAGR (%) by Region (2020-2032)

6.2. Global 1-Bromopropane for Pharmaceutical Use Market Product Outlook & Forecast (2021-2033) Volume (K)

6.2.1. Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) and CAGR (%) by Application (2020-2032)

6.2.2. Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) and CAGR (%) by Types (2020-2032)

6.2.3. Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) and CAGR (%) by Region (2020-2032)

7. Global 1-Bromopropane for Pharmaceutical Use Market Breakdown Data By Value (USD Million) (2020-2032)

7.1. Global 1-Bromopropane for Pharmaceutical Use Market by: Regions (Value)

7.1.1. North America

7.1.2. South America

7.1.3. Europe

7.1.4. Middle East & Africa

7.1.5. Asia Pacific

7.2. North America

7.2.1. North America Value (USD Million) (2020-2032) By Country

7.2.2. North America Value (USD Million) (2020-2032) by Application

7.2.3. North America Value (USD Million) (2020-2032) by Types

7.3. South America

7.3.1. South America Value (USD Million) (2020-2032) By Country

7.3.2. South America Value (USD Million) (2020-2032) by Application

7.3.3. South America Value (USD Million) (2020-2032) by Types

7.4. Europe

7.4.1. Europe Value (USD Million) (2020-2032) By Country

7.4.2. Europe Value (USD Million) (2020-2032) by Application

7.4.3. Europe Value (USD Million) (2020-2032) by Types

7.5. Middle East & Africa

7.5.1. Middle East & Africa Value (USD Million) (2020-2032) By Country

7.5.2. Middle East & Africa Value (USD Million) (2020-2032) by Application

7.5.3. Middle East & Africa Value (USD Million) (2020-2032) by Types

7.6. Asia Pacific

7.6.1. Asia Pacific Value (USD Million) (2020-2032) By Country

7.6.2. Asia Pacific Value (USD Million) (2020-2032) by Application

7.6.3. Asia Pacific Value (USD Million) (2020-2032) by Types

8. Global 1-Bromopropane for Pharmaceutical Use Market Breakdown Data By Volume (K) (2020-2032)

8.1. Global 1-Bromopropane for Pharmaceutical Use Market by: Regions (Volume)

8.1.1. North America

8.1.2. South America

8.1.3. Europe

8.1.4. Middle East & Africa

8.1.5. Asia Pacific

8.2. North America

8.2.1. North America Volume (K) (2020-2032) By Country

8.2.2. North America Volume (K) (2020-2032) by Application

8.2.3. North America Volume (K) (2020-2032) by Types

8.3. South America

8.3.1. South America Volume (K) (2020-2032) By Country

8.3.2. South America Volume (K) (2020-2032) by Application

8.3.3. South America Volume (K) (2020-2032) by Types

8.4. Europe

8.4.1. Europe Volume (K) (2020-2032) By Country

8.4.2. Europe Volume (K) (2020-2032) by Application

8.4.3. Europe Volume (K) (2020-2032) by Types

8.5. Middle East & Africa

8.5.1. Middle East & Africa Volume (K) (2020-2032) By Country

8.5.2. Middle East & Africa Volume (K) (2020-2032) by Application

8.5.3. Middle East & Africa Volume (K) (2020-2032) by Types

8.6. Asia Pacific

8.6.1. Asia Pacific Volume (K) (2020-2032) By Country

8.6.2. Asia Pacific Volume (K) (2020-2032) by Application

8.6.3. Asia Pacific Volume (K) (2020-2032) by Types

9. Global 1-Bromopropane for Pharmaceutical Use Market Competition by Key Manufacturers

9.1. Global 1-Bromopropane for Pharmaceutical Use Revenue (USD Million) and Market Share (%) by Manufacturers (2024)

9.2. Player's Concentration

9.2.1. Top 5 Manufacturers

9.2.2. Top 3 Manufacturers

9.3. Market Entropy

Global 1-Bromopropane for Pharmaceutical Use: Profiled Players Head Office and Area Served

9.4. Key Player Products/Services

9.4.1 Merger & Acquisitions and Expansion Plans

10. Company Profile

10.1. Albemarle

10.1.1. Company Basic Information and Sales Area

10.1.2. Main Business/Business Overview

10.1.3. Product Portfolio

10.1.4. Financial

10.1.5. Recent Industry Insights

10.1.6. SWOT Analysis

10.2. Chemtura

10.2.1. Company Basic Information and Sales Area

10.2.2. Main Business/Business Overview

10.2.3. Product Portfolio

10.2.4. Financial

10.2.5. Recent Industry Insights

10.2.6. SWOT Analysis

10.3. ICL

10.3.1. Company Basic Information and Sales Area

10.3.2. Main Business/Business Overview

10.3.3. Product Portfolio

10.3.4. Financial

10.3.5. Recent Industry Insights

10.3.6. SWOT Analysis

10.4. Weifang Longwei

10.4.1. Company Basic Information and Sales Area

10.4.2. Main Business/Business Overview

10.4.3. Product Portfolio

10.4.4. Financial

10.4.5. Recent Industry Insights

10.4.6. SWOT Analysis

10.5. Solaris Chemtech

10.5.1. Company Basic Information and Sales Area

10.5.2. Main Business/Business Overview

10.5.3. Product Portfolio

10.5.4. Financial

10.5.5. Recent Industry Insights

10.5.6. SWOT Analysis

10.6. Longsheng Chemical

10.6.1. Company Basic Information and Sales Area

10.6.2. Main Business/Business Overview

10.6.3. Product Portfolio

10.6.4. Financial

10.6.5. Recent Industry Insights

10.6.6. SWOT Analysis

10.7. Tongcheng Medical

10.7.1. Company Basic Information and Sales Area

10.7.2. Main Business/Business Overview

10.7.3. Product Portfolio

10.7.4. Financial

10.7.5. Recent Industry Insights

10.7.6. SWOT Analysis

10.8. Shandong Moris Tech

10.8.1. Company Basic Information and Sales Area

10.8.2. Main Business/Business Overview

10.8.3. Product Portfolio

10.8.4. Financial

10.8.5. Recent Industry Insights

10.8.6. SWOT Analysis

10.9. Shenrunfa

10.9.1. Company Basic Information and Sales Area

10.9.2. Main Business/Business Overview

10.9.3. Product Portfolio

10.9.4. Financial

10.9.5. Recent Industry Insights

10.9.6. SWOT Analysis

10.10. Shouguang Fukang Pharmaceutical

10.10.1. Company Basic Information and Sales Area

10.10.2. Main Business/Business Overview

10.10.3. Product Portfolio

10.10.4. Financial

10.10.5. Recent Industry Insights

10.10.6. SWOT Analysis

10.11. Shouguang Luyuan Salt Chemical

10.11.1. Company Basic Information and Sales Area

10.11.2. Main Business/Business Overview

10.11.3. Product Portfolio

10.11.4. Financial

10.11.5. Recent Industry Insights

10.11.6. SWOT Analysis

10.12. Jinbiao Chemical

10.12.1. Company Basic Information and Sales Area

10.12.2. Main Business/Business Overview

10.12.3. Product Portfolio

10.12.4. Financial

10.12.5. Recent Industry Insights

10.12.6. SWOT Analysis

10.13. Nova International

10.13.1. Company Basic Information and Sales Area

10.13.2. Main Business/Business Overview

10.13.3. Product Portfolio

10.13.4. Financial

10.13.5. Recent Industry Insights

10.13.6. SWOT Analysis

10.14. Infinity Scientific

10.14.1. Company Basic Information and Sales Area

10.14.2. Main Business/Business Overview

10.14.3. Product Portfolio

10.14.4. Financial

10.14.5. Recent Industry Insights

10.14.6. SWOT Analysis

10.15. Ataman Kimya

10.15.1. Company Basic Information and Sales Area

10.15.2. Main Business/Business Overview

10.15.3. Product Portfolio

10.15.4. Financial

10.15.5. Recent Industry Insights

10.15.6. SWOT Analysis

11. Methodology/Research Approach

11.1. Research Programs/Material Type

11.2. Market Size Estimation

11.3. Market Breakdown and Data Triangulation

12. Data Sources

12.1. Secondary Sources

12.2. Primary Sources

List of Figures

40 items

Figure 1: Key Leading Regions

Figure 2: Key Leading Companies

Figure 3: Global 1-Bromopropane for Pharmaceutical Use Market

Figure 4: Global 1-Bromopropane for Pharmaceutical Use Market: Drivers

Figure 5: Global 1-Bromopropane for Pharmaceutical Use Market: Challenges

Figure 6: Global 1-Bromopropane for Pharmaceutical Use Market: Trends

Figure 7: Global 1-Bromopropane for Pharmaceutical Use Market: Opportunity

Figure 8: Global 1-Bromopropane for Pharmaceutical Use Market: Restraint

Figure 9: Global 1-Bromopropane for Pharmaceutical Use Market: Porter's Five Forces

Figure 10: Global Market Value (USD Million) (2020-2024) By Application

Figure 11: Global Market Share (%) By Application (2024)

Figure 12: Global Market Value (USD Million) (2020-2024) By Types

Figure 13: Global Market Share (%) By Types (2024)

Figure 14: Global Market Volume (K) (2020-2024) By Application

Figure 15: Global Market Share (%) By Application (2024)

Figure 16: Global Market Volume (K) (2020-2024) By Types

Figure 17: Global Market Share (%) By Types (2024)

Figure 18: Global 1-Bromopropane for Pharmaceutical Use Market Value (USD Million) By Region

Figure 19: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By: Regions (2024)

Figure 20: Top 5 Manufacturers

Figure 21: Top 3 Manufacturers

Figure 22: Global Market Value (USD Million) (2025-2032) By Application

Figure 23: Global Market Share (%) By Application (2032)

Figure 24: Global Market Value (USD Million) (2025-2032) By Types

Figure 25: Global Market Share (%) By Types (2032)

Figure 26: Global 1-Bromopropane for Pharmaceutical Use Market Value (USD Million) By Region

Figure 27: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By: Regions (2032)

Figure 28: Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) By Region

Figure 29: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By: Regions (2024)

Figure 30: Top 5 Manufacturers

Figure 31: Top 3 Manufacturers

Figure 32: Global Market Volume (K) (2025-2032) By Application

Figure 33: Global Market Share (%) By Application (2032)

Figure 34: Global Market Volume (K) (2025-2032) By Types

Figure 35: Global Market Share (%) By Types (2032)

Figure 36: Global 1-Bromopropane for Pharmaceutical Use Market Value (USD Million) By Region

Figure 37: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By: Regions (2032)

Figure 38: Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) By Region

Figure 39: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By: Regions (2032)

Figure 40: Data Triangulation

List of Tables

125 items

Table 1: Market Segmentation Analysis

Table 2: Global 1-Bromopropane for Pharmaceutical Use Revenue (USD Million) And Cagr (%) By Application (2020-2032)

Table 3: Global 1-Bromopropane for Pharmaceutical Use Revenue (USD Million) And Cagr (%) By Types (2020-2032)

Table 4: Global 1-Bromopropane for Pharmaceutical Use Revenue (USD Million) And Cagr (%) By Region (2020-2032)

Table 5: Global Market Value (USD Million) (2020-2024) By Application

Table 6: Global Market Share (%) By Application (2024)

Table 7: Global Market Value (USD Million) (2020-2024) By Types

Table 8: Global Market Share (%) By Types (2024)

Table 9: Global Market Volume (K) (2020-2024) By Application

Table 10: Global Market Share (%) By Application (2024)

Table 11: Global Market Volume (K) (2020-2024) By Types

Table 12: Global Market Share (%) By Types (2024)

Table 13: Global 1-Bromopropane for Pharmaceutical Use Market Value (USD Million) By Region

Table 14: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By Region

Table 15: North America Market Value (USD Million) (2020-2024) By Country

Table 16: North America Market Value (USD Million) (2020-2024) By Application

Table 17: North America Market Value (USD Million) (2020-2024) By Types

Table 18: Europe Market Value (USD Million) (2020-2024) By Country

Table 19: Europe Market Value (USD Million) (2020-2024) By Application

Table 20: Europe Market Value (USD Million) (2020-2024) By Types

Table 21: Asia Pacific Market Value (USD Million) (2020-2024) By Country

Table 22: Asia Pacific Market Value (USD Million) (2020-2024) By Application

Table 23: Asia Pacific Market Value (USD Million) (2020-2024) By Types

Table 24: South America Market Value (USD Million) (2020-2024) By Country

Table 25: South America Market Value (USD Million) (2020-2024) By Application

Table 26: South America Market Value (USD Million) (2020-2024) By Types

Table 27: Middle East & Africa Market Value (USD Million) (2020-2024) By Country

Table 28: Middle East & Africa Market Value (USD Million) (2020-2024) By Application

Table 29: Middle East & Africa Market Value (USD Million) (2020-2024) By Types

Table 30: Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) By Region

Table 31: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By Region

Table 32: North America Market Volume (K) (2020-2024) By Country

Table 33: North America Market Volume (K) (2020-2024) By Application

Table 34: North America Market Volume (K) (2020-2024) By Types

Table 35: Europe Market Volume (K) (2020-2024) By Country

Table 36: Europe Market Volume (K) (2020-2024) By Application

Table 37: Europe Market Volume (K) (2020-2024) By Types

Table 38: Asia Pacific Market Volume (K) (2020-2024) By Country

Table 39: Asia Pacific Market Volume (K) (2020-2024) By Application

Table 40: Asia Pacific Market Volume (K) (2020-2024) By Types

Table 41: South America Market Volume (K) (2020-2024) By Country

Table 42: South America Market Volume (K) (2020-2024) By Application

Table 43: South America Market Volume (K) (2020-2024) By Types

Table 44: Middle East & Africa Market Volume (K) (2020-2024) By Country

Table 45: Middle East & Africa Market Volume (K) (2020-2024) By Application

Table 46: Middle East & Africa Market Volume (K) (2020-2024) By Types

Table 47: Global 1-Bromopropane for Pharmaceutical Use Market Revenue (USD Million) And Market Share (%) Of Key Manufacturers (2024)

Table 48: Global 1-Bromopropane for Pharmaceutical Use Market: Profiled Players Head Office And Area Served

Table 49: Key Players Global 1-Bromopropane for Pharmaceutical Use Market:

Table 50: Mergers & Acquisitions, Expansion Plans

Table 51: Albemarle Basic Information And Sales Area

Table 52: Albemarle. Products Portfolio

Table 53: Chemtura Basic Information And Sales Area

Table 54: Chemtura. Products Portfolio

Table 55: ICL Basic Information And Sales Area

Table 56: ICL. Products Portfolio

Table 57: Weifang Longwei Basic Information And Sales Area

Table 58: Weifang Longwei. Products Portfolio

Table 59: Solaris Chemtech Basic Information And Sales Area

Table 60: Solaris Chemtech. Products Portfolio

Table 61: Longsheng Chemical Basic Information And Sales Area

Table 62: Longsheng Chemical. Products Portfolio

Table 63: Tongcheng Medical Basic Information And Sales Area

Table 64: Tongcheng Medical. Products Portfolio

Table 65: Shandong Moris Tech Basic Information And Sales Area

Table 66: Shandong Moris Tech. Products Portfolio

Table 67: Shenrunfa Basic Information And Sales Area

Table 68: Shenrunfa. Products Portfolio

Table 69: Shouguang Fukang Pharmaceutical Basic Information And Sales Area

Table 70: Shouguang Fukang Pharmaceutical. Products Portfolio

Table 71: Shouguang Luyuan Salt Chemical Basic Information And Sales Area

Table 72: Shouguang Luyuan Salt Chemical. Products Portfolio

Table 73: Jinbiao Chemical Basic Information And Sales Area

Table 74: Jinbiao Chemical. Products Portfolio

Table 75: Nova International Basic Information And Sales Area

Table 76: Nova International. Products Portfolio

Table 77: Infinity Scientific Basic Information And Sales Area

Table 78: Infinity Scientific. Products Portfolio

Table 79: Ataman Kimya Basic Information And Sales Area

Table 80: Ataman Kimya. Products Portfolio

Table 81: Global Market Value (USD Million) (2025-2032) By Application

Table 82: Global Market Share (%) By Application (2032)

Table 83: Global Market Value (USD Million) (2025-2032) By Types

Table 84: Global Market Share (%) By Types (2032)

Table 85: Global Market Volume (K) (2025-2032) By Application

Table 86: Global Market Share (%) By Application (2032)

Table 87: Global Market Volume (K) (2025-2032) By Types

Table 88: Global Market Share (%) By Types (2032)

Table 89: Global 1-Bromopropane for Pharmaceutical Use Market Value (USD Million) By Region

Table 90: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By Region (2025-2032)

Table 91: North America Market Value (USD Million) (2025-2032) By Country

Table 92: North America Market Value (USD Million) (2025-2032) By Application

Table 93: North America Market Value (USD Million) (2025-2032) By Types

Table 94: Europe Market Value (USD Million) (2025-2032) By Country

Table 95: Europe Market Value (USD Million) (2025-2032) By Application

Table 96: Europe Market Value (USD Million) (2025-2032) By Types

Table 97: Asia Pacific Market Value (USD Million) (2025-2032) By Country

Table 98: Asia Pacific Market Value (USD Million) (2025-2032) By Application

Table 99: Asia Pacific Market Value (USD Million) (2025-2032) By Types

Table 100: South America Market Value (USD Million) (2025-2032) By Country

Table 101: South America Market Value (USD Million) (2025-2032) By Application

Table 102: South America Market Value (USD Million) (2025-2032) By Types

Table 103: Middle East & Africa Market Value (USD Million) (2025-2032) By Country

Table 104: Middle East & Africa Market Value (USD Million) (2025-2032) By Application

Table 105: Middle East & Africa Market Value (USD Million) (2025-2032) By Types

Table 106: Global 1-Bromopropane for Pharmaceutical Use Market Volume (K) By Region

Table 107: Global 1-Bromopropane for Pharmaceutical Use Market Share (%) By Region (2025-2032)

Table 108: North America Market Volume (K) (2025-2032) By Country

Table 109: North America Market Volume (K) (2025-2032) By Application

Table 110: North America Market Volume (K) (2025-2032) By Types

Table 111: Europe Market Volume (K) (2025-2032) By Country

Table 112: Europe Market Volume (K) (2025-2032) By Application

Table 113: Europe Market Volume (K) (2025-2032) By Types

Table 114: Asia Pacific Market Volume (K) (2025-2032) By Country

Table 115: Asia Pacific Market Volume (K) (2025-2032) By Application

Table 116: Asia Pacific Market Volume (K) (2025-2032) By Types

Table 117: South America Market Volume (K) (2025-2032) By Country

Table 118: South America Market Volume (K) (2025-2032) By Application

Table 119: South America Market Volume (K) (2025-2032) By Types

Table 120: Middle East & Africa Market Volume (K) (2025-2032) By Country

Table 121: Middle East & Africa Market Volume (K) (2025-2032) By Application

Table 122: Middle East & Africa Market Volume (K) (2025-2032) By Types

Table 123: Research Programs/Design For This Report

Table 124: Key Data Information From Secondary Sources

Table 125: Key Data Information From Primary Sources

FAQs

1. What is the current 1-Bromopropane for Pharmaceutical Use market size?

The 1-Bromopropane for Pharmaceutical Use market size reached roughly USD 1.15 billion in 2023, driven by expanding API synthesis and solvent applications across North America and Europe, marking a solid baseline for upcoming growth phases globally.

2. What is the projected growth forecast for the market through 2032?

Analysts project a compound annual growth rate of 6.2 % from 2024 to 2032, expanding the market to approximately USD 2.1 billion by the end of the forecast period, propelled by rising demand in specialty drug manufacturing.

3. Which key drivers are fueling market expansion?

The market’s expansion is fueled by increasing adoption of 1‑Bromopropane as a high‑efficiency halogenating agent, cost‑effective synthesis routes for active pharmaceutical ingredients, and heightened focus on greener solvent alternatives that meet stringent purity standards globally.

4. What are the main challenges facing the market?

Key challenges include regulatory scrutiny over volatile organic compound emissions, competition from alternative brominating reagents with lower toxicity, supply chain volatility for raw bromine, and the need for extensive worker safety training in high‑volume production facilities.

5. Which regions are leading the market?

North America remains the regional leader, driven by robust pharmaceutical pipelines, while Europe follows closely due to stringent environmental regulations encouraging greener solvents. Emerging growth is observed in Asia‑Pacific, particularly China and India, where generic drug manufacturing is expanding rapidly.

6. Who are the top companies operating in this market?

Leading players include BASF SE, Dow Chemical Company, Eastman Chemical Company, LyondellBasell Industries, and Innospec Inc., each investing in process optimization, strategic partnerships, and portfolio diversification to capture larger shares of the 1‑Bromopropane for Pharmaceutical Use market.

7. What future opportunities are emerging for the market?

Future opportunities arise from the development of novel drug delivery systems requiring precise halogenation, expansion into biopharmaceutical intermediates, and collaborations with renewable‑chemistry initiatives that aim to lower the carbon footprint of bromination processes globally over the next decade.

8. How is technology impacting market dynamics?

Advanced catalytic systems and continuous flow reactors are improving reaction efficiency, reducing waste, and enabling real‑time monitoring of 1‑Bromopropane usage. Digital twins and AI‑driven process control further accelerate scale‑up while maintaining product quality across global.

9. What is the regulatory landscape for 1‑Bromopropane in pharma?

The regulatory environment combines OSHA occupational exposure limits, EPA VOC restrictions, and EMA/ FDA guidelines on residual solvents. Companies must file risk assessments and comply with REACH registration, shaping product formulation and manufacturing site selection.

Contact for Full Report

Loading report content...

1-Bromopropane for Pharmaceutical Use Market: Opportunity by 2034 | In-Depth Report

Market Snapshot

1-Bromopropane for Pharmaceutical Use Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

1-Bromopropane for Pharmaceutical Use Segmentation

1-Bromopropane for Pharmaceutical Use Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current 1-Bromopropane for Pharmaceutical Use market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are fueling market expansion?

4. What are the main challenges facing the market?

5. Which regions are leading the market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology impacting market dynamics?

9. What is the regulatory landscape for 1‑Bromopropane in pharma?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation

Market Snapshot

1-Bromopropane for Pharmaceutical Use Market Overview

Report Overview

Market Dynamics

Market Segmentation

Regional Insights

Competitive Landscape

Market Ecosystem

Recent Industry Insights

Analyst Overview

1-Bromopropane for Pharmaceutical Use Segmentation

1-Bromopropane for Pharmaceutical Use Segmentation by Geography

Table of Contents

Table of Contents

List of Figures

List of Tables

FAQs

1. What is the current 1-Bromopropane for Pharmaceutical Use market size?

2. What is the projected growth forecast for the market through 2032?

3. Which key drivers are fueling market expansion?

4. What are the main challenges facing the market?

5. Which regions are leading the market?

6. Who are the top companies operating in this market?

7. What future opportunities are emerging for the market?

8. How is technology impacting market dynamics?

9. What is the regulatory landscape for 1‑Bromopropane in pharma?

Methodology

Step 1 - Selecting Representative Samples from the Population

Step 2 - Methods for Estimating Market Size (Value, Volume & Price*)

Step 3 - Information Sources

📘 Direct Research

📚 Indirect Research

Step 4 - Data Validation & Triangulation